Concepedia

Thomas Podsadecki

TP

Statistics

Publications

47

Citations

6.4K

H-Index

31

Active since

2006

Affiliations

AbbVie (United States)(Current)

The University of Texas at San Antonio Health Science Center

Texas Liver Institute

Abbott Fund

Virginia Mason Medical Center

Thomas Podsadecki is an author at AbbVie (United States) specializing in antiviral therapy, antiviral pharmacotherapy, and pharmacy.

Publications per year

2006–2017

47

Publications

47

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

Jordan J. Feld, Kris V. Kowdley, Eoin Coakley et al. · New England Journal of Medicine · 2014 · 907 citations · Full text

, , +17

ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

Fred Poordad, Christophe Hézode, Roger Trinh et al. · New England Journal of Medicine · 2014 · 877 citations · Full text

, , +17

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

Péter Ferenci, David Bernstein, Jacob Lalezari et al. · New England Journal of Medicine · 2014 · 695 citations · Full text

, , +16

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

Stefan Zeuzem, Ira M. Jacobson, Tolga Baykal et al. · New England Journal of Medicine · 2014 · 519 citations · Full text

, , +17

ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection

Pietro Andreoné, Massimo Colombo, Jeffrey Enejosa et al. · Gastroenterology · 2014 · 369 citations · Full text

, , +17

1–5 of 47